Calcium2026-06

[Osteodystrophy in chronic liver disease].

Eiken Pia, Al-Omran Atheer Adel, Schiødt Frank Vinholt — Ugeskrift for laeger

Summary

This paper discusses hepatic osteodystrophy, a bone condition that can affect individuals with long-term liver disease. It highlights that this condition often leads to weakened bones and fractures, emphasizing the importance of early screening and treatments like calcium and vitamin D to help strengthen bones.

AI-generated summary — read the original

Key points

Chronic liver disease can lead to a bone condition called hepatic osteodystrophy.
This condition often results in weakened bones and an increased risk of fractures.
Screening for bone weakness is recommended for older patients with chronic liver disease.
Treatments include calcium, vitamin D, and specific medications to improve bone health.

What the study looked at

This paper reviewed the current understanding of hepatic osteodystrophy, a bone disorder that can develop in individuals with long-term liver disease. It aimed to summarize how this condition affects bones and what treatments are available. This was a review article, meaning the authors synthesized information from existing scientific literature on hepatic osteodystrophy. It did not involve new experiments or a specific group of study participants, but rather drew conclusions from previously published research on patients with chronic liver disease. The review found that hepatic osteodystrophy commonly causes osteoporosis, a condition where bones become brittle, leading to fragility fractures. It suggests that people over 50 with chronic liver disease, especially those who have experienced fractures, should be screened for osteoporosis. The paper highlighted that treatments typically involve calcium and vitamin D supplementation, along with lifestyle changes. Additionally, certain medications like bisphosphonates and denosumab were noted to help increase bone density in these patients.

Dietary takeaway

For individuals with chronic liver disease, ensuring adequate calcium intake through diet or supplements, alongside vitamin D, is an important step in supporting bone health. While this review highlights the role of calcium in managing bone issues related to liver disease, remember that one study provides guidance, not definitive proof, and personalized advice from a healthcare provider is always best.

Abstract

Hepatic osteodystrophy is defined as a metabolic bone disease that may occur in individuals with chronic liver disease (CLD). Hepatic osteodystrophy commonly manifests with osteoporosis and fragility fractures. This review finds that patients older than 50 years with CLD should be screened for possible osteoporosis earlier if they experience fragility fractures. Treatment includes calcium, vitamin D, and lifestyle interventions. Bisphosphonates, such as alendronate, and denosumab increase bone mineral density in CLD patients.

View on PubMed →DOI: 10.61409/V12230769